Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T63068 | Target Info | |||
Target Name | Serum albumin (ALB) | ||||
Synonyms | Serum albumin | ||||
Target Type | Successful Target | ||||
Gene Name | ALB | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Lauric acid | Ligand Info | |||
Canonical SMILES | CCCCCCCCCCCC(=O)O | ||||
InChI | 1S/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14) | ||||
InChIKey | POULHZVOKOAJMA-UHFFFAOYSA-N | ||||
PubChem Compound ID | 3893 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 1E7F HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID) | ||||||
Method | X-ray diffraction | Resolution | 2.43 Å | Mutation | No | [1] |
PDB Sequence |
HKSEVAHRFK
12 DLGEENFKAL22 VLIAFAQYLQ32 QCPFEDHVKL42 VNEVTEFAKT52 CVADESAENC 62 DKSLHTLFGD72 KLCTVATLRE82 TYGEMADCCA92 KQEPERNECF102 LQHKDDNPNL 112 PRLVRPEVDV122 MCTAFHDNEE132 TFLKKYLYEI142 ARRHPYFYAP152 ELLFFAKRYK 162 AAFTECCQAA172 DKAACLLPKL182 DELRDEGKAS192 SAKQRLKCAS202 LQKFGERAFK 212 AWAVARLSQR222 FPKAEFAEVS232 KLVTDLTKVH242 TECCHGDLLE252 CADDRADLAK 262 YICENQDSIS272 SKLKECCEKP282 LLEKSHCIAE292 VENDEMPADL302 PSLAADFVES 312 KDVCKNYAEA322 KDVFLGMFLY332 EYARRHPDYS342 VVLLLRLAKT352 YETTLEKCCA 362 AADPHECYAK372 VFDEFKPLVE382 EPQNLIKQNC392 ELFEQLGEYK402 FQNALLVRYT 412 KKVPQVSTPT422 LVEVSRNLGK432 VGSKCCKHPE442 AKRMPCAEDY452 LSVVLNQLCV 462 LHEKTPVSDR472 VTKCCTESLV482 NRRPCFSALE492 VDETYVPKEF502 NAETFTFHAD 512 ICTLSEKERQ522 IKKQTALVEL532 VKHKPKATKE542 QLKAVMDDFA552 AFVEKCCKAD 562 DKETCFAEEG572 KKLVAASQAA582 LG
|
|||||
|
VAL7
4.497
ARG10
3.864
LEU14
3.882
PHE19
3.273
LEU22
4.136
VAL23
3.710
ALA26
4.477
VAL46
3.733
PHE49
3.440
LEU66
3.611
LEU69
3.480
PHE70
3.516
LYS73
3.963
LEU115
4.404
ARG117
3.022
MET123
4.788
PHE134
4.651
LEU135
3.190
TYR138
3.551
LEU139
3.714
ILE142
4.991
TYR150
2.671
PRO152
3.874
ALA158
4.000
TYR161
3.741
PHE165
3.848
LEU182
4.224
ARG186
4.488
LYS199
4.611
ARG209
3.370
ALA210
4.103
LYS212
4.152
ALA213
3.814
VAL216
4.860
ARG218
3.343
LEU219
3.709
ARG222
3.662
PHE223
4.549
LEU238
3.519
VAL241
4.878
HIS242
3.533
LEU251
3.618
ALA254
3.759
ARG257
2.641
ALA258
4.087
LEU260
4.359
ILE264
4.239
LEU283
3.626
LEU284
3.791
SER287
2.425
ILE290
3.974
ALA291
3.538
ASP324
4.153
LEU327
4.064
GLY328
3.929
SER342
2.979
VAL344
3.411
LEU345
4.161
LEU347
4.036
ARG348
2.675
ALA350
4.130
LYS351
4.277
GLU354
3.976
PRO384
3.666
LEU387
3.576
ILE388
3.600
ASN391
4.067
TYR401
2.954
PHE403
4.996
ASN405
3.673
ARG410
3.084
TYR411
2.665
VAL415
3.505
VAL418
3.915
THR422
4.462
LEU423
4.578
VAL426
3.872
LEU430
3.702
VAL433
3.600
GLY434
3.910
MET446
4.423
ALA449
4.228
GLU450
4.196
LEU453
3.751
LEU457
3.974
LEU460
3.568
SER480
4.315
VAL482
4.300
ARG485
3.394
PRO486
4.840
PHE488
3.822
SER489
2.778
PHE507
3.495
PHE509
4.705
LYS525
2.908
ALA528
4.401
LEU529
4.226
LEU532
3.559
VAL547
3.580
MET548
3.471
PHE551
3.613
ALA552
3.966
LEU575
4.604
VAL576
4.298
SER579
3.919
|
|||||
PDB ID: 5VNW Crystal structure of Nb.b201 bound to human serum albumin | ||||||
Method | X-ray diffraction | Resolution | 2.60 Å | Mutation | No | [2] |
PDB Sequence |
AHKSEVAHRF
11 KDLGEENFKA21 LVLIAFAQYL31 QQCPFEDHVK41 LVNEVTEFAK51 TCVADESAEN 61 CDKSLHTLFG71 DKLCTVATLR81 ETYGEMADCC91 AKQEPERNEC101 FLQHKDDNPN 111 LPRLVRPEVD121 VMCTAFHDNE131 ETFLKKYLYE141 IARRHPYFYA151 PELLFFAKRY 161 KAAFTECCQA171 ADKAACLLPK181 LDELRDEGKA191 SSAKQRLKCA201 SLQKFGERAF 211 KAWAVARLSQ221 RFPKAEFAEV231 SKLVTDLTKV241 HTECCHGDLL251 ECADDRADLA 261 KYICENQDSI271 SSKLKECCEK281 PLLEKSHCIA291 EVENDEMPAD301 LPSLAADFVE 311 SKDVCKNYAE321 AKDVFLGMFL331 YEYARRHPDY341 SVVLLLRLAK351 TYETTLEKCC 361 AAADPHECYA371 KVFDEFKPLV381 EEPQNLIKQN391 CELFEQLGEY401 KFQNALLVRY 411 TKKVPQVSTP421 TLVEVSRNLG431 KVGSKCCKHP441 EAKRMPCAED451 YLSVVLNQLC 461 VLHEKTPVSD471 RVTKCCTESL481 VNRRPCFSAL491 EVDETYVPKE501 FNAETFTFHA 511 DICTLSEKER521 QIKKQTALVE531 LVKHKPKATK541 EQLKAVMDDF551 AAFVEKCCKA 561 DDKETCFAEE571 GKKLVAASQA581 ALG
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol. 2000 Nov 10;303(5):721-32. | ||||
REF 2 | Yeast surface display platform for rapid discovery of conformationally selective nanobodies. Nat Struct Mol Biol. 2018 Mar;25(3):289-296. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.